• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Choose life: Why patients in China refuse standard treatment for a type of heart attack

Bioengineer by Bioengineer
March 31, 2021
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Scientists identify numerous variables that predict the treatment decisions of patients with a type of heart attach called ST-elevation myocardial infarction

IMAGE

Credit: Jesse Orrico on Unsplash

ST segment-elevation myocardial infarction (STEMI) is a particularly severe type of heart attack associated with a high risk of mortality or long-term disability. Clinicians can reduce a patient’s chances of unfavorable outcomes by performing a procedure known as percutaneous coronary intervention (PCI), which combines coronary angioplasty–in which a balloon is inserted into a blocked artery of the heart to clear it–with stenting–inserting a tiny tube into a blocked artery to keep the line open. But studies in China have found that many patients with STEMI choose not to undergo PCI and that women with STEMI, in particular, have a reduced likelihood of undergoing guideline-based management and acute reperfusion therapy.

The phenomenon of patients with STEMI refusing PCI attracted the interest of a research team at China’s Shandong University. As lead researcher of the team, Dr. Yu-Guo Chen explains, “Understanding the factors that influence patients’ decisions to reject medical advice may facilitate efforts to improve treatment compliance, quality of care, and prognoses.” Dr. Chen and team conducted analyses of treatment data to identify the predictors of PCI refusal for patients with STEMI. Their results appear in a paper published in a recent edition of the Chinese Medical Journal.

For their analyses, the researchers used data that had been prospectively collected through a cohort study involving patients with STEMI who presented to any of six Chinese emergency departments between August 2015 and September 2017. After excluding patients who never had the opportunity to decide whether to undergo PCI, as well as patients transferred to other hospitals and those discharged against the treating clinicians’ advice, the researchers had a dataset of 957 patients, including 260 women and 697 men. On this dataset, they used multivariable logistic regression analyses to identify the predictors of PCI refusal.

In total, 98 of the patients in the dataset (10.2%) chose not to undergo PCI. One factor that had a major influence on their decisions was age, with patients older than 65 years being more likely than their younger counterparts to refuse PCI. Some important predictors of PCI refusal were having a history of myocardial infarction, experiencing cardiac shock while in the emergency department, a more than 12-hour delay in reaching the hospital after STEMI onset, and having a faster heart rate.

Some other factors included being married, receiving treatment at a tertiary hospital, and having a higher body mass index value.

Interestingly, comparisons between male and female patients showed that female patients were older, were less likely to be married, had lower body mass index values on average, and were less likely to receive treatment at tertiary hospitals. Given that these factors were all predictors of PCI refusal in the regression model, these differences may help to explain why women with STEMI are more likely to refuse PCI than their male counterparts are.

In conclusion, the researchers at Shandong University have identified a host of factors that may help to predict whether a patient with STEMI will give or withhold consent to PCI. When asked about the long-term medical and societal importance of these findings, Dr. Chen notes that knowledge of these predictors may aid healthcare providers in their efforts to persuade more patients with STEMI to consent to PCI. He predicts that increasing the number of patients who undergo PCI “will lead to reductions in mortality and improvements in long-term clinical outcomes.” Given the sex disparities in PCI refusal rates, such improvements may be of particular value to Chinese women.

Percutaneous coronary intervention is the recommended procedure after ST-elevation myocardial infarction, but some patients refuse to undergo it. Researchers from Shandong University, China, have identified some demographic and clinical features associated with such treatment refusal.

###

Photo courtesy: Jesse Orrico on Unsplash

Reference

Titles of original papers: Analysis of potential factors contributing to refusal of invasive strategy after ST-segment elevation myocardial infarction in China.

Journal: Chinese Medical Journal

DOI:10.1097/CM9.0000000000001171

Media Contact
Peifang Wei
[email protected]

Related Journal Article

http://dx.doi.org/10.1097/CM9.0000000000001171

Tags: BiologyCardiologyDeath/DyingDevelopmental/Reproductive BiologyHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthResearch/DevelopmentStroke
Share14Tweet9Share2ShareShareShare2

Related Posts

The Active Role of Repetitive DNA in the Human Brain Uncovered

The Active Role of Repetitive DNA in the Human Brain Uncovered

August 25, 2025
Durable and Efficient H2 Evolution Achieved with Strongly Coupled Pt–N-Mo Cluster Heterostructure in Anion-Exchange Membrane Electrolyzers

Durable and Efficient H2 Evolution Achieved with Strongly Coupled Pt–N-Mo Cluster Heterostructure in Anion-Exchange Membrane Electrolyzers

August 25, 2025

Sugars Signal Guard Cell Ion Transport in Red Light

August 25, 2025

Innovative 3D-Printed Scaffolds Pave the Way for Spinal Cord Injury Recovery

August 25, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    143 shares
    Share 57 Tweet 36
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary Cyclic Thioether Additive Boosts Lithium Metal Batteries to 3,000 Stable Cycles!

Breakthroughs in Screening Techniques and Point-of-Care Diagnostics Transform Colorectal Cancer Detection

Introducing the Second Beijing Consensus on Holistic Integrative Medicine for Managing Helicobacter pylori-Associated Disease-Syndrome

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.